Captrust Financial Advisors boosted its stake in Aetna Inc (NYSE:AET) by 6.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 6,953 shares of the company’s stock after acquiring an additional 404 shares during the quarter. Captrust Financial Advisors’ holdings in Aetna were worth $1,254,000 as of its most recent filing with the SEC.
Other institutional investors also recently added to or reduced their stakes in the company. Focused Wealth Management Inc lifted its holdings in Aetna by 84.5% in the 4th quarter. Focused Wealth Management Inc now owns 655 shares of the company’s stock valued at $118,000 after purchasing an additional 300 shares in the last quarter. Cerebellum GP LLC purchased a new position in Aetna in the 4th quarter valued at $125,000. James Hambro & Partners purchased a new position in Aetna in the 4th quarter valued at $158,000. Harel Insurance Investments & Financial Services Ltd. purchased a new position in Aetna in the 4th quarter valued at $180,000. Finally, Signature Estate & Investment Advisors LLC purchased a new position in Aetna in the 4th quarter valued at $182,000. 87.34% of the stock is currently owned by hedge funds and other institutional investors.
A number of brokerages have weighed in on AET. Piper Jaffray Companies restated a “buy” rating and issued a $212.00 price objective on shares of Aetna in a report on Tuesday, January 30th. ValuEngine upgraded Aetna from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Credit Suisse Group raised their price objective on Aetna from $200.00 to $208.00 and gave the company a “neutral” rating in a report on Wednesday, January 31st. Citigroup lowered Aetna from a “buy” rating to a “neutral” rating and raised their price objective for the company from $187.89 to $212.00 in a report on Wednesday, January 31st. Finally, Cowen restated a “buy” rating and issued a $212.00 price objective on shares of Aetna in a report on Tuesday, January 30th. Nine equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $189.50.
Aetna (NYSE:AET) last issued its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.07. The firm had revenue of $14.74 billion for the quarter, compared to analyst estimates of $14.79 billion. Aetna had a net margin of 3.15% and a return on equity of 21.50%. Aetna’s revenue was down 6.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.08 EPS. equities analysts predict that Aetna Inc will post 11.06 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, April 12th will be issued a $0.50 dividend. The ex-dividend date is Wednesday, April 11th. This represents a $2.00 annualized dividend and a yield of 1.13%. Aetna’s dividend payout ratio (DPR) is currently 34.78%.
ILLEGAL ACTIVITY NOTICE: This report was first published by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/03/14/aetna-inc-aet-shares-bought-by-captrust-financial-advisors.html.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.